Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mangold

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Journal of the American Academy of Dermatology|February 26, 2025
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort studyKathryn T Shahwan, Trent D Walker, Andrea Tan, et al.
Journal of the American Academy of Dermatology|May 20, 2020
Deep learning for dermatologists: Part II. Current applicationsPranav Puri, Nneka Comfere, Lisa A Drage, et al.
American Journal of Clinical Dermatology|September 25, 2025
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell CarcinomaLindsey M Voller, Kelsey E Hirotsu, Sumaira Z Aasi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen PlanopilarisAlyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Excision With Total Margin Control Versus Vertical Section Margin Assessment for NCCN Very High-Risk Cutaneous Squamous Cell CarcinomaDavid M Wang, Nina A Ran, Emily E Granger, et al.
Journal of the American Academy of Dermatology|November 5, 2025
Development of a gene-expression panel predictive of local recurrence, metastasis, and overall survival in intermediate- to high-risk cutaneous squamous cell carcinoma: A cohort studyZachary Leibovit-Reiben, Alyssa Stockard, Shams Nassir, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Prognostic determinants of early and late relapse in cutaneous squamous cell carcinoma: a multicenter retrospective cohort studySergio Rodríguez-Conde, Cristian D Cardona-Machado, Nina A Ran, et al.
Journal of the American Academy of Dermatology|March 2, 2025
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinomaAnokhi Jambusaria-Pahlajani, Vincent Jeanselme, David M Wang, et al.
Journal of Surgical Oncology|July 12, 2026
Prognostic Factors in Primary Head and Neck Cutaneous Squamous Cell Carcinoma: A Large-Scale, Multi-Institutional Competing-Risks AnalysisFábio Muradás Girardi, Cristian David Cardona Machado, Ashley Wysong, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Oral Baricitinib in the Treatment of Cutaneous Lichen PlanusAngelina Hwang, Jacob Kechter, Tran Do, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Journal of the American Academy of Dermatology|February 26, 2025
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort studyKathryn T Shahwan, Trent D Walker, Andrea Tan, et al.
Journal of the American Academy of Dermatology|May 20, 2020
Deep learning for dermatologists: Part II. Current applicationsPranav Puri, Nneka Comfere, Lisa A Drage, et al.
American Journal of Clinical Dermatology|September 25, 2025
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell CarcinomaLindsey M Voller, Kelsey E Hirotsu, Sumaira Z Aasi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen PlanopilarisAlyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Excision With Total Margin Control Versus Vertical Section Margin Assessment for NCCN Very High-Risk Cutaneous Squamous Cell CarcinomaDavid M Wang, Nina A Ran, Emily E Granger, et al.
Journal of the American Academy of Dermatology|November 5, 2025
Development of a gene-expression panel predictive of local recurrence, metastasis, and overall survival in intermediate- to high-risk cutaneous squamous cell carcinoma: A cohort studyZachary Leibovit-Reiben, Alyssa Stockard, Shams Nassir, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Prognostic determinants of early and late relapse in cutaneous squamous cell carcinoma: a multicenter retrospective cohort studySergio Rodríguez-Conde, Cristian D Cardona-Machado, Nina A Ran, et al.
Journal of the American Academy of Dermatology|March 2, 2025
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinomaAnokhi Jambusaria-Pahlajani, Vincent Jeanselme, David M Wang, et al.
Journal of Surgical Oncology|July 12, 2026
Prognostic Factors in Primary Head and Neck Cutaneous Squamous Cell Carcinoma: A Large-Scale, Multi-Institutional Competing-Risks AnalysisFábio Muradás Girardi, Cristian David Cardona Machado, Ashley Wysong, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Oral Baricitinib in the Treatment of Cutaneous Lichen PlanusAngelina Hwang, Jacob Kechter, Tran Do, et al.
Pageof 11